Keywords: novartis, applies, femara, license, extension, usa, eu

Novartis applies for Femara license extension in USA and EU

Article | 18 July 2005

Print This

Switzerland's Novartis has submitted marketing authorization applications in the USA and Europe for the use of Femara (letrozole) in the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in